Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 102

1.

The effect of 17-alpha hydroxyprogesterone caproate on the risk of gestational diabetes in singleton or twin pregnancies.

Gyamfi C, Horton AL, Momirova V, Rouse DJ, Caritis SN, Peaceman AM, Sciscione A, Meis PJ, Spong CY, Dombrowski M, Sibai B, Varner MW, Iams JD, Mercer BM, Carpenter MW, Lo J, Ramin SM, O'Sullivan MJ, Miodovnik M, Conway D; Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network.

Am J Obstet Gynecol. 2009 Oct;201(4):392.e1-5. doi: 10.1016/j.ajog.2009.06.036. Epub 2009 Aug 29.

PMID:
19716543
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

17α-hydroxyprogesterone caproate for the prevention of adverse neonatal outcome in multiple pregnancies: a randomized controlled trial.

Lim AC, Schuit E, Bloemenkamp K, Bernardus RE, Duvekot JJ, Erwich JJ, van Eyck J, Groenwold RH, Hasaart TH, Hummel P, Kars MM, Kwee A, van Oirschot CM, van Pampus MG, Papatsonis D, Porath MM, Spaanderman ME, Willekes C, Wilpshaar J, Mol BW, Bruinse HW.

Obstet Gynecol. 2011 Sep;118(3):513-20. doi: 10.1097/AOG.0b013e31822ad6aa.

PMID:
21860279
[PubMed - indexed for MEDLINE]
3.

Prevention of preterm birth in triplets using 17 alpha-hydroxyprogesterone caproate: a randomized controlled trial.

Caritis SN, Rouse DJ, Peaceman AM, Sciscione A, Momirova V, Spong CY, Iams JD, Wapner RJ, Varner M, Carpenter M, Lo J, Thorp J, Mercer BM, Sorokin Y, Harper M, Ramin S, Anderson G; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), Maternal-Fetal Medicine Units Network (MFMU).

Obstet Gynecol. 2009 Feb;113(2 Pt 1):285-92. doi: 10.1097/AOG.0b013e318193c677.

PMID:
19155896
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

A trial of 17 alpha-hydroxyprogesterone caproate to prevent prematurity in twins.

Rouse DJ, Caritis SN, Peaceman AM, Sciscione A, Thom EA, Spong CY, Varner M, Malone F, Iams JD, Mercer BM, Thorp J, Sorokin Y, Carpenter M, Lo J, Ramin S, Harper M, Anderson G; National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network.

N Engl J Med. 2007 Aug 2;357(5):454-61.

PMID:
17671253
[PubMed - indexed for MEDLINE]
Free Article
5.

Inefficacy of 17 alpha-hydroxyprogesterone caproate in the prevention of prematurity in twin pregnancy.

Hartikainen-Sorri AL, Kauppila A, Tuimala R.

Obstet Gynecol. 1980 Dec;56(6):692-5.

PMID:
7443111
[PubMed - indexed for MEDLINE]
6.

Second trimester cervical length and risk of preterm birth in women with twin gestations treated with 17-α hydroxyprogesterone caproate.

Durnwald CP, Momirova V, Rouse DJ, Caritis SN, Peaceman AM, Sciscione A, Varner MW, Malone FD, Mercer BM, Thorp JM Jr, Sorokin Y, Carpenter MW, Lo J, Ramin SM, Harper M, Spong CY; Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network.

J Matern Fetal Neonatal Med. 2010 Dec;23(12):1360-4. doi: 10.3109/14767051003702786. Epub 2010 May 4.

PMID:
20441408
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Effect of 17alpha-hydroxyprogesterone caproate on glucose intolerance in pregnancy.

Waters TP, Schultz BA, Mercer BM, Catalano PM.

Obstet Gynecol. 2009 Jul;114(1):45-9. doi: 10.1097/AOG.0b013e3181a9454b.

PMID:
19546757
[PubMed - indexed for MEDLINE]
8.

Relationship between 17-alpha hydroxyprogesterone caproate concentration and spontaneous preterm birth.

Caritis SN, Venkataramanan R, Thom E, Harper M, Klebanoff MA, Sorokin Y, Thorp JM Jr, Varner MW, Wapner RJ, Iams JD, Carpenter MW, Grobman WA, Mercer BM, Sciscione A, Rouse DJ, Ramin S; Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network and Obstetric-Fetal Pharmacology Research Units Network.

Am J Obstet Gynecol. 2014 Feb;210(2):128.e1-6. doi: 10.1016/j.ajog.2013.10.008. Epub 2013 Oct 7.

PMID:
24113254
[PubMed - indexed for MEDLINE]
9.

The rates of abnormal glucose challenge tests and gestational diabetes in women receiving 17α-hydroxyprogesterone caproate.

Wolfe K, Dearmond C, How H, Henderson ZT, Sibai B.

Am J Perinatol. 2011 Dec;28(10):741-6. doi: 10.1055/s-0031-1280854. Epub 2011 Jun 9.

PMID:
21660898
[PubMed - indexed for MEDLINE]
10.

17-hydroxyprogesterone caproate for twin pregnancy: a double-blind, randomized clinical trial.

Combs CA, Garite T, Maurel K, Das A, Porto M; Obstetrix Collaborative Research Network.

Am J Obstet Gynecol. 2011 Mar;204(3):221.e1-8. doi: 10.1016/j.ajog.2010.12.042.

PMID:
21376161
[PubMed - indexed for MEDLINE]
11.

Prevention of preterm delivery by 17 alpha-hydroxyprogesterone caproate in asymptomatic twin pregnancies with a short cervix: a randomized controlled trial.

Senat MV, Porcher R, Winer N, Vayssière C, Deruelle P, Capelle M, Bretelle F, Perrotin F, Laurent Y, Connan L, Langer B, Mantel A, Azimi S, Rozenberg P; Groupe de Recherche en Obstétrique et Gynécologie.

Am J Obstet Gynecol. 2013 Mar;208(3):194.e1-8. doi: 10.1016/j.ajog.2013.01.032.

PMID:
23433324
[PubMed - indexed for MEDLINE]
12.

Does progesterone treatment influence risk factors for recurrent preterm delivery?

Meis PJ, Klebanoff M, Dombrowski MP, Sibai BM, Leindecker S, Moawad AH, Northen A, Iams JD, Varner MW, Caritis SN, O'Sullivan MJ, Miodovnik M, Leveno KJ, Conway D, Wapner RJ, Carpenter M, Mercer B, Ramin SM, Thorp JM, Peaceman AM, Gabbe S.

Obstet Gynecol. 2005 Sep;106(3):557-61.

PMID:
16135587
[PubMed - indexed for MEDLINE]
13.

Women receiving 17-alpha-hydroxyprogesterone caproate hospitalized for preterm labor at less than 34 weeks benefit from daily perinatal nursing surveillance.

Rittenberg C, Sullivan S, Istwan N, Rhea D, Stanziano G, Newman R.

Am J Obstet Gynecol. 2008 Oct;199(4):389.e1-4. doi: 10.1016/j.ajog.2008.06.070.

PMID:
18928983
[PubMed - indexed for MEDLINE]
14.

17alpha-hydroxyprogesterone caproate for the prevention of preterm delivery: A cost-effectiveness analysis.

Odibo AO, Stamilio DM, Macones GA, Polsky D.

Obstet Gynecol. 2006 Sep;108(3 Pt 1):492-9.

PMID:
16946206
[PubMed - indexed for MEDLINE]
15.

Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate.

Meis PJ, Klebanoff M, Thom E, Dombrowski MP, Sibai B, Moawad AH, Spong CY, Hauth JC, Miodovnik M, Varner MW, Leveno KJ, Caritis SN, Iams JD, Wapner RJ, Conway D, O'Sullivan MJ, Carpenter M, Mercer B, Ramin SM, Thorp JM, Peaceman AM, Gabbe S; National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network.

N Engl J Med. 2003 Jun 12;348(24):2379-85. Erratum in: N Engl J Med. 2003 Sep 25;349(13):1299.

PMID:
12802023
[PubMed - indexed for MEDLINE]
Free Article
16.

Effect of 17-alpha hydroxyprogesterone caproate on cervical length in twin pregnancies.

Lim AC, Schuit E, Papatsonis D, van Eyck J, Porath MM, van Oirschot CM, Hummel P, Hasaart TH, Kleiverda G, de Graaf IM, van Ginkel AA, Mol BW, Bruinse HW.

Ultrasound Obstet Gynecol. 2012 Oct;40(4):426-30. doi: 10.1002/uog.11174.

PMID:
23008102
[PubMed - indexed for MEDLINE]
Free Article
17.

Increased incidence of gestational diabetes in women receiving prophylactic 17alpha-hydroxyprogesterone caproate for prevention of recurrent preterm delivery.

Rebarber A, Istwan NB, Russo-Stieglitz K, Cleary-Goldman J, Rhea DJ, Stanziano GJ, Saltzman DH.

Diabetes Care. 2007 Sep;30(9):2277-80. Epub 2007 Jun 11.

PMID:
17563346
[PubMed - indexed for MEDLINE]
18.

Progesterone for the prevention of preterm birth in women with multiple pregnancies: the AMPHIA trial.

Lim AC, Bloemenkamp KW, Boer K, Duvekot JJ, Erwich JJ, Hasaart TH, Hummel P, Mol BW, Offermans JP, van Oirschot CM, Santema JG, Scheepers HC, Schöls WA, Vandenbussche FP, Wouters MG, Bruinse HW; AMPHIA study group.

BMC Pregnancy Childbirth. 2007 Jun 19;7:7.

PMID:
17578562
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Relationship between 17-hydroxyprogesterone caproate concentrations and gestational age at delivery in twin gestation.

Caritis SN, Simhan HN, Zhao Y, Rouse DJ, Peaceman AM, Sciscione A, Spong CY, Varner MW, Malone FD, Iams JD, Mercer BM, Thorp JM Jr, Sorokin Y, Carpenter M, Lo J, Ramin SM, Harper M; Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network.

Am J Obstet Gynecol. 2012 Nov;207(5):396.e1-8. doi: 10.1016/j.ajog.2012.08.001. Epub 2012 Aug 6.

PMID:
22959763
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Progesterone for prevention of recurrent preterm birth: impact of gestational age at previous delivery.

Spong CY, Meis PJ, Thom EA, Sibai B, Dombrowski MP, Moawad AH, Hauth JC, Iams JD, Varner MW, Caritis SN, O'Sullivan MJ, Miodovnik M, Leveno KJ, Conway D, Wapner RJ, Carpenter M, Mercer B, Ramin SM, Thorp JM, Peaceman AM, Gabbe S; National Institute of Child Health and Human Development Maternal Fetal Medicine Units Network.

Am J Obstet Gynecol. 2005 Sep;193(3 Pt 2):1127-31.

PMID:
16157124
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk